Vol. 4, Issue 1-2, 2022May 12, 2022 BST
Clinical, Morphological and Clonal Progression of VEXAS Syndrome in the Context of Myelodysplasia Treated with Azacytidine
Clinical, Morphological and Clonal Progression of VEXAS Syndrome in the Context of Myelodysplasia Treated with Azacytidine
Marco Manzoni, Alessandro Bosi, Sonia Fabris, Marta Lionetti, Simone Salerio, Anna Chiara Migliorini, Francesca Cavallaro, Kordelia Barbullushi, Nicolò Rampi, Vittorio Montefusco, Maria Grazia Alessio, Antonino Neri, Luca Baldini, Mariarita Sciumè, Elena Tagliaferri, Nicola Fracchiolla, Niccolò Bolli,
Manzoni, Marco, Alessandro Bosi, Sonia Fabris, Marta Lionetti, Simone Salerio, Anna Chiara Migliorini, Francesca Cavallaro, et al. 2022. “Clinical, Morphological and Clonal Progression of VEXAS Syndrome in the Context of Myelodysplasia Treated with Azacytidine.” Clinical Hematology International 4 (1–2): 52–55. https://doi.org/10.1007/s44228-022-00002-w.